These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 10047503)

  • 1. Structure-based and combinatorial search for new RNA-binding drugs.
    Afshar M; Prescott CD; Varani G
    Curr Opin Biotechnol; 1999 Feb; 10(1):59-63. PubMed ID: 10047503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular dynamics simulation and binding energy calculation for estimation of oligonucleotide duplex thermostability in RNA-based therapeutics.
    Shen L; Johnson TL; Clugston S; Huang H; Butenhof KJ; Stanton RV
    J Chem Inf Model; 2011 Aug; 51(8):1957-65. PubMed ID: 21702481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serendipity meets precision: the integration of structure-based drug design and combinatorial chemistry for efficient drug discovery.
    Salemme FR; Spurlino J; Bone R
    Structure; 1997 Mar; 5(3):319-24. PubMed ID: 9083110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction methods and databases within chemoinformatics: emphasis on drugs and drug candidates.
    Jónsdóttir SO; Jørgensen FS; Brunak S
    Bioinformatics; 2005 May; 21(10):2145-60. PubMed ID: 15713739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RECAP--retrosynthetic combinatorial analysis procedure: a powerful new technique for identifying privileged molecular fragments with useful applications in combinatorial chemistry.
    Lewell XQ; Judd DB; Watson SP; Hann MM
    J Chem Inf Comput Sci; 1998; 38(3):511-22. PubMed ID: 9611787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Informatics and modeling challenges in fragment-based drug discovery.
    Hubbard RE; Chen I; Davis B
    Curr Opin Drug Discov Devel; 2007 May; 10(3):289-97. PubMed ID: 17554855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases.
    Ghose AK; Viswanadhan VN; Wendoloski JJ
    J Comb Chem; 1999 Jan; 1(1):55-68. PubMed ID: 10746014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design of small molecule libraries for NMR screening and other applications in drug discovery.
    Jacoby E; Davies J; Blommers MJ
    Curr Top Med Chem; 2003; 3(1):11-23. PubMed ID: 12570776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ligand efficiency indices as guideposts for drug discovery.
    Abad-Zapatero C; Metz JT
    Drug Discov Today; 2005 Apr; 10(7):464-9. PubMed ID: 15809192
    [No Abstract]   [Full Text] [Related]  

  • 10. Leadlikeness and structural diversity of synthetic screening libraries.
    Verheij HJ
    Mol Divers; 2006 Aug; 10(3):377-88. PubMed ID: 17031539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metal complexes in medicinal chemistry: new vistas and challenges in drug design.
    Thompson KH; Orvig C
    Dalton Trans; 2006 Feb; (6):761-4. PubMed ID: 16437168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combinatorial approaches in anticancer drug discovery: recent advances in design and synthesis.
    Bhattacharyya S
    Curr Med Chem; 2001 Oct; 8(12):1383-404. PubMed ID: 11562273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antisense drug discovery and development.
    Yamamoto T; Nakatani M; Narukawa K; Obika S
    Future Med Chem; 2011 Mar; 3(3):339-65. PubMed ID: 21446846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting RNA with Small Molecules To Capture Opportunities at the Intersection of Chemistry, Biology, and Medicine.
    Disney MD
    J Am Chem Soc; 2019 May; 141(17):6776-6790. PubMed ID: 30896935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design of diversity and focused combinatorial libraries in drug discovery.
    Young SS; Ge N
    Curr Opin Drug Discov Devel; 2004 May; 7(3):318-24. PubMed ID: 15216935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Organic chemistry in drug discovery.
    MacCoss M; Baillie TA
    Science; 2004 Mar; 303(5665):1810-3. PubMed ID: 15031494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guanine-tethered antisense oligonucleotides as synthetic riboregulators.
    Hagihara M
    Methods Mol Biol; 2014; 1111():197-207. PubMed ID: 24549621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug discovery in the kinase inhibitory field using the Nested Chemical Library technology.
    Kéri G; Székelyhidi Z; Bánhegyi P; Varga Z; Hegymegi-Barakonyi B; Szántai-Kis C; Hafenbradl D; Klebl B; Muller G; Ullrich A; Erös D; Horváth Z; Greff Z; Marosfalvi J; Pató J; Szabadkai I; Szilágyi I; Szegedi Z; Varga I; Wáczek F; Orfi L
    Assay Drug Dev Technol; 2005 Oct; 3(5):543-51. PubMed ID: 16305311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical substructures in drug discovery.
    Merlot C; Domine D; Cleva C; Church DJ
    Drug Discov Today; 2003 Jul; 8(13):594-602. PubMed ID: 12850335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lead optimization via high-throughput molecular docking.
    Joseph-McCarthy D; Baber JC; Feyfant E; Thompson DC; Humblet C
    Curr Opin Drug Discov Devel; 2007 May; 10(3):264-74. PubMed ID: 17554852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.